Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project

被引:0
作者
Nina Wilson
Katie Biggs
Sarah Bowden
Julia Brown
Munyaradzi Dimairo
Laura Flight
Jamie Hall
Anna Hockaday
Thomas Jaki
Rachel Lowe
Caroline Murphy
Philip Pallmann
Mark A. Pilling
Claire Snowdon
Matthew R. Sydes
Sofía S. Villar
Christopher J. Weir
Jessica Welburn
Christina Yap
Rebecca Maier
Helen Hancock
James M. S. Wason
机构
[1] Newcastle University,Population Health Sciences Institute
[2] University of Sheffield,School of Health and Related Research (ScHARR)
[3] University of Birmingham,Cancer Research UK Clinical Trials Unit (CRCTU)
[4] University of Leeds,Leeds Institute of Clinical Trials Research
[5] University of Cambridge,MRC Biostatistics Unit
[6] Lancaster University,Department of Mathematics and Statistics
[7] Cardiff University,Centre for Trials Research
[8] King’s College London,King’s College Trials Unit
[9] University of Cambridge,Department of Public Health and Primary Care
[10] The Institute of Cancer Research Clinical Trials & Statistics Unit,Edinburgh Clinical Trials Unit, Usher Institute
[11] MRC Clinical Trials Unit at UCL,Newcastle Clinical Trials Unit
[12] University of Edinburgh,undefined
[13] Newcastle University,undefined
来源
BMC Medicine | / 19卷
关键词
Adaptive designs; Adaptive clinical trials; Clinical trials; Efficiency; Resource requirements; Trial coordination;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 147 条
[1]  
DiMasi JA(2016)Innovation in the pharmaceutical industry: new estimates of R&D costs J Health Econ. 47 20-33
[2]  
Grabowski HG(2019)Conducting clinical trials—costs, impacts, and the value of clinical trials networks: a scoping review Clin Trials. 16 183-193
[3]  
Hansen RW(2018)Adaptive designs in clinical trials: why use them, and how to run and report them BMC Med. 16 1-15
[4]  
Bentley C(2020)The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design BMJ. 369 m115-180
[5]  
Cressman S(2020)Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs BMC Med. 18 352-346
[6]  
van der Hoek K(2018)Practical characteristics of adaptive design in phase 2 and 3 clinical trials J Clin Pharm Ther. 43 170-16
[7]  
Arts K(2018)Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov BMJ Open 8 e018320-10
[8]  
Dancey J(2013)Uptake of novel statistical methods for early-phase clinical studies in the UK public sector Clin Trials. 10 344-497
[9]  
Peacock S(2015)Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials Trials. 16 1-11
[10]  
Pallmann P(2020)Stakeholder perspectives on adaptive clinical trials: A scoping review Trials. 21 1-100